BTL Emsella
BTL Emsella is a non-invasive medical device that uses high-intensity focused electromagnetic (HIFEM) technology to stimulate pelvic floor muscles for treating urinary incontinence. FDA cleared BTL Emsella in 2018 for stress and urge urinary incontinence, as documented by the FDA’s 510(k) database.
Most US insurance plans, including Aetna and UnitedHealthcare, classify BTL Emsella as investigational or experimental and do not cover it as of June 2024. Medicare does not reimburse for BTL Emsella treatments according to CMS guidelines published in 2023.
Out-of-pocket costs per session average $300–$500 at clinics such as Mayo Clinic and Cleveland Clinic. Clinical studies report over 95% patient satisfaction after six sessions, based on data from peer-reviewed journals like the International Urogynecology Journal (2019).
Patients typically require two sessions per week for three weeks, totaling six sessions per treatment protocol according to manufacturer recommendations. Side effects are mild and may include temporary muscle soreness or tingling, reported by less than 5% of patients in clinical trials, as determined by YourInsuranceInfo.
Is BTL Emsella covered by insurance?
Yes, BTL Emsella may be covered by insurance. Insurance coverage depends on the individual policy and plan of the patient. It is best to check with your insurance provider to see if BTL Emsella treatments are covered under their policies. Some health insurers may cover a portion or all of the costs associated with this…
See also Buckeye Acceptance, and Buccal fat removal.